Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1991
12/29/1991CA2045867A1 N-monosubstituted adamantyl/norbornanyl 17_beta-carbamides of 3-carboxy-androsts-3,5-dienes as testosterone 5 alpha-reductase inhibitors
12/29/1991CA2045866A1 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
12/29/1991CA2045865A1 Intermediates on the synthesis of 17 beta-acyl-3-carboxy-androsta-3,5-dienes
12/29/1991CA2045289A1 3,3'-dithiobis(propionic acids) and esters thereof
12/29/1991CA2044564A1 Amino acid derivatives
12/28/1991WO1992000072A1 Tetrahydroisoquinolinylcarbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indole
12/28/1991WO1991016914A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
12/28/1991CA2082418A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
12/28/1991CA2045755A1 Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use
12/28/1991CA2045730A1 Process for the preparation of substituted acyclic nucleosides, and intermediates occurring therein
12/28/1991CA2045450A1 1,2,3,4,5,6-hexahydro-azepino¬4,5-b|indoles and 1,2,3,4-tetrahydro- .beta.-carbolines, their preparation process and pharmaceutical compositions containing them
12/28/1991CA2045445A1 New compounds of 4-amino butyric acid, the process for their preparation and the pharmaceuticals containing them
12/28/1991CA2045073A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
12/28/1991CA2036287A1 Polynucleotide phosphorodithioate as therapeutic agents for retroviral infections
12/28/1991CA2020018A1 Method and composition for treating the migraine complex
12/27/1991EP0462949A1 1-alkyl-3-(acylamino)-epsilon-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same
12/27/1991EP0462948A2 Pharmaceutical compositions comprising 3-amino-epsilon-caprolactames for enhancing learning and memory
12/27/1991EP0462935A1 Enantiomers of 2-tetrahydrofuran derivatives, intermediates therefor and their preparation
12/27/1991EP0462933A1 Novel N-benzyl-N1-phenyl and -phenalkyl-thioureas
12/27/1991EP0462813A2 Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase
12/27/1991EP0462812A2 Pyran derivatives as inhibitors of 5-lipoxygenase
12/27/1991EP0462808A2 Inhibitors of HIV reverse transcriptase
12/27/1991EP0462800A2 Inhibitors of HIV reverse transcriptase
12/27/1991EP0462761A2 Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
12/27/1991EP0462721A2 Novel Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from Bacillus thuringiensis isolates
12/27/1991EP0462696A1 Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines
12/27/1991EP0462668A2 New 17beta-aminobenzoyl-4-aza-5alpha-androst-1-en-3-ones as benign prostatic hypertrophy agents
12/27/1991EP0462667A2 Beta-lactams as antihypercholesterolemics
12/27/1991EP0462665A2 Selected 17beta-polyaroyl-4-aza-5alpha-androst-1-en-3-ones as steroidal reductase inhibitors
12/27/1991EP0462664A2 Specific 17beta-thiobenzoyl-4-aza-5alpha-androst-1-en-3-ones as antiandrogenic agents
12/27/1991EP0462662A2 17beta-N-monosubstituted adamantyl/norbornanyl carbamoyl-4-aza-5alpha-androst-1-en-3-ones and androstan-3-ones
12/27/1991EP0462661A2 Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors
12/27/1991EP0462638A1 Pyridinylpiperazine derivatives
12/27/1991EP0462631A1 Methods and compositions for the treatment of gastrointestinal disorders
12/27/1991EP0462621A2 Use of particular compounds for manufacture of pharmaceutical formulations for treatment against various parasites, mycoplasmas, other indications and other infections
12/27/1991EP0462556A2 Hypotriglyceridemic use of certain bis(3,5-di-alkyl-4-hydroxphenylthio)methanes
12/27/1991EP0462522A1 Aminobenzodiazepines
12/27/1991EP0462506A1 Pharmaceutical preparations of mixtures comprising cefotaxim and derivatives of xanthine and their use
12/27/1991EP0462468A2 9-amino-2-phenylbicyclo(3.3.1)nonane and 9-amino-2-phenylbicyclo(3.3.1)-non-2-ene and therapeutic agents containing them
12/27/1991EP0462398A1 TGF-beta compositions
12/27/1991EP0462292A1 Salt eliminant composition
12/27/1991EP0462291A1 Acat enzyme inhibiting composition
12/27/1991EP0462290A1 Lipid absorption inhibiting composition
12/27/1991EP0462264A1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists.
12/27/1991EP0462207A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression
12/27/1991EP0462206A1 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
12/27/1991EP0462179A1 Novel sulfonamides as radiosensitizers
12/27/1991EP0462177A1 Purified insulin mediators and purification process for same
12/27/1991EP0462150A1 Novel aryloxy alkyl amines, their production and medicaments containing them.
12/27/1991CA2045449A1 2-phenanthrenyl carbapenems
12/27/1991CA2045432A1 2-phenanthrenyl-carbapenem antibacterial agents
12/27/1991CA2045428A1 Method for enhancing the lowering of plasma cholesterol levels
12/27/1991CA2045422A1 2-biphenyl-carbapenhems
12/27/1991CA2045419A1 2-(heteroaryl substituted) phenyl carbapenem antibacterial agents
12/27/1991CA2045388A1 2-biphenyl-carbapenem antibacterial agents
12/27/1991CA2019996A1 Immunoregulatory agents
12/26/1991WO1992000066A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
12/26/1991WO1991019978A1 Using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for detecting and treating lung cancers
12/26/1991WO1991019977A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER
12/26/1991WO1991019813A1 Nucleic acid ligands
12/26/1991WO1991019734A2 Thrombin inhibitors based on the amino acid sequence of hirudin
12/26/1991WO1991019731A1 Steroids which inhibit angiogenesis
12/26/1991WO1991019726A1 Ether lipid-nucleoside covalent conjugates
12/26/1991WO1991019716A1 Antitumor substance be-13793c
12/26/1991WO1991019713A1 Pyrimidine nucleoside derivative
12/26/1991WO1991019712A1 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
12/26/1991WO1991019710A1 New salt form
12/26/1991WO1991019709A1 Imidazolylbenzoyl substituted heterocycles
12/26/1991WO1991019708A1 New thiophene derivatives
12/26/1991WO1991019700A1 Pharmaceutically active benzoquinazoline compounds
12/26/1991WO1991019514A1 An anticoagulant preparation
12/26/1991WO1991019510A1 Osteoinductive pharmaceutical formulations
12/26/1991WO1991019501A1 Intercellular adhesion mediators
12/26/1991WO1991019500A1 Pharmaceutical compositions containing acetylsalicylic acid and vitamin b6
12/26/1991WO1991019499A1 N-desmethyl - deacetyl diltiazem for use in reducing hypertension
12/26/1991WO1991019496A1 Hypolipidemic agent
12/26/1991WO1991019495A1 Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease
12/26/1991WO1991019492A1 Process for activating reproduction of seasonal breeding animals by administering l-dihydroxyphenylalanine (l-dopa)
12/26/1991WO1991019491A1 Use of calcium soap for the treatment of inflammatory skin reactions in horses and ponies
12/26/1991WO1991019490A1 Pgf 1-alcohols and their use as ocular hypotensives
12/26/1991WO1991019489A1 METHOD FOR REGULATING RUMINAL pH
12/26/1991WO1991019488A1 REDUCTION OF CARDIOVASCULAR VESSEL OCCLUSIONS WITH ASCORBATE AND LIPOPROTEIN (a) BINDING INHIBITORS
12/26/1991WO1991019482A1 Aminosteroids for ophthalmic use
12/26/1991WO1991019479A1 Compositions comprising vitamin d precursors, analogs thereof and their use
12/26/1991WO1991019418A1 Treatment of disease
12/26/1991WO1991017773A3 New protein-polycation conjugates
12/26/1991WO1991016045A3 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
12/26/1991CA2574895A1 Nucleic acid ligands
12/26/1991CA2085585A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
12/26/1991CA2085101A1 An anticoagulant preparation
12/26/1991CA2084769A1 Pgf 1-alcohols and their use as ocular hypotensives
12/26/1991CA2045413A1 Tricyclic antipsychotic agents
12/26/1991CA2045293A1 Bisphosphonic acid derivatives, their production and use
12/26/1991CA2045262A1 Antimicrobial fatty acid compositions
12/26/1991CA2044846A1 Antagonists of immunosuppressive macrolides
12/26/1991CA2044366A1 Cardiotonic pharmaceutical composition
12/26/1991CA2019797A1 Method and composition for treating nasal disorders and headaches
12/25/1991WO1992000296A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands
12/25/1991CN1057295A Process for isolation and expression of human ciliary neuronotrophic factor by recombinant dna technology
12/25/1991CN1057263A (3h,7h) thiazolo (3,4-a) pyridines with antiasthmatic and antiinflammatory actions on the respiratory tract
1 ... 7304 7305 7306 7307 7308 7309 7310 7311 7312 7313 7314 7315 7316 7317 7318 7319 7320 7321 7322 7323 7324 ... 7860